Pennant Capital Management’s Elevance Health ELV Stock Holding History

Pennant Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-183,379	Closed	-$41.3M	–	27
2017 Q4	$41.3M	Sell	183,379 -10,421	-5%	-$2.22M	3.74%	10
2017 Q3	$36.8M	Sell	193,800 -32,200	-14%	-$6.13M	2.26%	20
2017 Q2	$42.5M	Buy	+226,000	New	+$40.6M	2.5%	19

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pennant Capital Management's ELV Position: Q1 2018 in Review

Pennant Capital Management sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 183,379 shares — an estimated $41.3M sold.

Pennant Capital Management first reported a position in ELV in Q2 2017 and held it in 3 quarters. The position peaked at $42.5M in Q2 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

Pennant Capital Management reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
Pennant Capital Management sold 183,379 Elevance Health shares in Q1 2018, an estimated $41.3M.
Pennant Capital Management first reported a position in Elevance Health in Q2 2017 and held it in 3 quarters.
Pennant Capital Management's Elevance Health position peaked at $42.5M in Q2 2017.
922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Pennant Capital Management's 13F filing for Q1 2018, filed 15 May 2018.